Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1400593

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1400593

Breast Cancer Therapeutics Market - By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy), Global Forecast, 2023-2032

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Breast Cancer Therapeutics Market will witness 7.3% CAGR between 2023 and 2032 propelled by novel events and robust research and development within the breast cancer domain. Emerging studies uncover innovative therapies, driving demand for advanced treatment options.

For instance, in December 2023, at the 2023 San Antonio Breast Cancer Symposium (SABCS), research spotlighted investigational treatments offering improved outcomes for metastatic breast cancer patients and insights into treatment resistance. One such research, The HER2CLIMB-02 trial revealed that incorporating tucatinib into trastuzumab emtansine (T-DM1) therapy extended progression-free survival (PFS) among individuals with previously treated HER2-positive metastatic or locally advanced breast cancer. Breakthroughs in precision medicine, immunotherapy, and targeted therapies amplify market growth, meeting the escalating need for more effective and personalized breast cancer treatments. With a dynamic landscape of scientific discoveries and evolving events, the market responds to the continuous quest for improved outcomes and enhanced therapies in the fight against breast cancer

The overall Breast Cancer Therapeutics Market share is classified based on therapy, and region.

The market size from the chemotherapy segment will register a noteworthy CAGR from 2023 to 2032. Despite advancements in targeted therapies, chemotherapy retains its significance, especially in aggressive cancer types. Its role in neoadjuvant and adjuvant settings, alongside emerging combination therapies, sustains demand. With ongoing refinements to minimize side effects and enhance efficacy, chemotherapy maintains a pivotal stance, meeting the needs of diverse patient profiles. Its enduring role in breast cancer treatment continues to fuel demand within the therapeutics market, ensuring comprehensive care and treatment options for patients.

Asia Pacific breast cancer therapeutics industry will showcase a commendable CAGR from 2023 to 2032. rising incidences and a growing focus on healthcare infrastructure. As breast cancer rates surge across Asia Pacific, there's an increased emphasis on innovative therapies and advanced treatment options. With evolving healthcare systems and a shift toward personalized medicine, the demand for targeted therapies and cutting-edge treatments rises. This burgeoning market caters to the region's quest for improved outcomes, fostering a dynamic landscape of breast cancer therapeutics within Asia Pacific's healthcare domain.

For instance, in December 2023, A collaborative effort between Pfizer, Monash University, and the Cancer Therapeutics Cooperative Research Centre, in Australia uncovered a potential pre-clinical drug for Estrogen Receptor (ER) positive breast cancer. This study unveiled CTx-648, an orally bioavailable 'KAT6A/B' inhibitor showing remarkable selectivity and potency. In mouse models, CTx-648 demonstrated significant anti-tumor effects in ER-positive breast cancer, even in cases resistant to hormone therapy. This breakthrough introduces a new prospect for targeting KAT6A in ER-positive breast cancer, potentially offering a novel treatment avenue for patients.

Product Code: 466

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast Calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Breast cancer therapeutics industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Therapy trends

Chapter 3 Breast Cancer Therapeutics Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing burden of breast cancer
      • 3.2.1.2 Increasing investments in R&D
      • 3.2.1.3 Launch of several diagnostic and screening programs
      • 3.2.1.4 Favorable insurance and reimbursement policies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Adverse-effects associated with breast cancer drugs
      • 3.2.2.2 High cost of drugs
    • 3.2.3 Growth potential analysis
    • 3.2.4 By therapy
  • 3.3 COVID-19 impact analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Breast Cancer Therapeutics Market Estimates and Forecast, By Therapy, 2018-2032 (USD Million)

  • 5.1 Key trends, by therapy
  • 5.2 Targeted therapy
  • 5.3 Hormonal therapy
  • 5.4 Chemotherapy
  • 5.5 Immunotherapy

Chapter 6 Breast Cancer Therapeutics Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by region
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 UK
    • 6.3.3 France
    • 6.3.4 Spain
    • 6.3.5 Italy
    • 6.3.6 Rest of Europe
  • 6.4 Asia Pacific
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Australia
    • 6.4.5 Rest of Asia Pacific
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
    • 6.5.3 Rest of Latin America
  • 6.6 Middle East & Africa
    • 6.6.1 South Africa
    • 6.6.2 Saudi Arabia
    • 6.6.3 Rest of Middle East & Africa

Chapter 7 Company Profiles

  • 7.1 AstraZeneca plc.
  • 7.2 Eli Lilly & Co, Inc.
  • 7.3 Pfizer, Inc.
  • 7.4 Novartis AG
  • 7.5 Amgen
  • 7.6 F. Hoffmann La Roche AG
  • 7.7 Merck & Co, Inc.
  • 7.8 Gilead Sciences, Inc.
  • 7.9 Eisai Co., Ltd.
  • 7.10 Macrogenics, Inc.
  • 7.11 Stemline Therapeutics, Inc.
Product Code: 466

Data Tables

  • TABLE 1 Market revenue, by therapy (2022)
  • TABLE 2 Market share, by region (2022)
  • TABLE 3 Global breast cancer therapeutics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 4 Global breast cancer therapeutics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 5 Global breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 6 Global breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 7 Industry impact forces
  • TABLE 8 Targeted therapy market size, 2018 - 2022 (USD Million)
  • TABLE 9 Targeted therapy market size, 2023 - 2032 (USD Million)
  • TABLE 10 Hormonal therapy market size, 2018 - 2022 (USD Million)
  • TABLE 11 Hormonal therapy market size, 2023 - 2032 (USD Million)
  • TABLE 12 Chemotherapy market size, 2018 - 2022 (USD Million)
  • TABLE 13 Chemotherapy market size, 2023 - 2032 (USD Million)
  • TABLE 14 Immunotherapy market size, 2018 - 2022 (USD Million)
  • TABLE 15 Immunotherapy market size, 2023 - 2032 (USD Million)
  • TABLE 16 North America breast cancer therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 17 North America breast cancer therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 18 North America breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 19 North America breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 20 U.S. breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 21 U.S. breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 22 Canada breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 23 Canada breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 24 Europe breast cancer therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 25 Europe breast cancer therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 26 Europe breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 27 Europe breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 28 Germany breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 29 Germany breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 30 UK breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 31 UK breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 32 France breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 33 France breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 34 Spain breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 35 Spain breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 36 Italy breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 37 Italy breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 38 Rest of Europe breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 39 Rest of Europe breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 40 Asia Pacific breast cancer therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 41 Asia Pacific breast cancer therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 42 Asia Pacific breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 43 Asia Pacific breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 44 China breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 45 China breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 46 Japan breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 47 Japan breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 48 India breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 49 India breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 50 Australia breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 51 Australia breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 52 Rest of Asia Pacific breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 53 Rest of Asia Pacific breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 54 Latin America breast cancer therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 55 Latin America breast cancer therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 56 Latin America breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 57 Latin America breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 58 Brazil breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 59 Brazil breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 60 Mexico breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 61 Mexico breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 62 Rest of Latin America breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 63 Rest of Latin America breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 64 Middle East & Africa breast cancer therapeutics market size, by country, 2018 - 2022 (USD Million)
  • TABLE 65 Middle East & Africa breast cancer therapeutics market size, by country, 2023 - 2032 (USD Million)
  • TABLE 66 Middle East & Africa breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 67 Middle East & Africa breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 68 South Africa breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 69 South Africa breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 70 Saudi Arabia breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 71 Saudi Arabia breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 72 Rest of Middle East & Africa breast cancer therapeutics market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 73 Rest of Middle East & Africa breast cancer therapeutics market size, by therapy, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Breast cancer therapeutics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, By Therapy
  • FIG 8 Porter's analysis
  • FIG 9 PESTEL analysis
  • FIG 10 Company matrix analysis, 2022
  • FIG 11 Competitive analysis of major market players, 2022
  • FIG 12 Competitive positioning matrix, 2022
  • FIG 13 Strategic dashboard, 2022
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!